Jyong Biotech Ltd. Ordinary Shares
MENS | NASDAQ
$1.92
+$0.04 (+2.13%)
Nov 2, 2026, 9:33 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 100K | 120K | 127K | 122K | 121K | n/a |
Gross Profit | -100K | -120K | -127K | -122K | -121K | n/a |
Operating Income | -2.61M | -2.06M | -2.8M | -2.83M | -2.4M | -2.45M |
Interest Income | 610K | 7K | 56K | 5K | 6K | n/a |
Pretax Income | -4.67M | -3.02M | -4.4M | -6.63M | -4.2M | -1.92M |
Net Income | -4.67M | -3.02M | -4.4M | -6.63M | -4.2M | -1.92M |
Selling & General & Admin | 1.78M | 1.13M | 1.73M | 1.54M | 845K | 931K |
Research & Development | 731K | 927K | 1.07M | 1.29M | 1.56M | 1.52M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.51M | 2.06M | 2.8M | 2.83M | 2.4M | 2.45M |
Interest Expense | 2.54M | 1.04M | 757K | 765K | 835K | 832K |
Selling & Marketing Expenses | n/a | 44K | 47K | 47K | 54K | 72K |
Cost & Expenses | 2.61M | 2.06M | 2.8M | 2.83M | 2.4M | 2.45M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 73.01M | 76.03M | 76.03M | 76.03M | 76.03M | 71.57M |
Shares Outstanding (Diluted) | 73.01M | 76.03M | 76.03M | 76.03M | 76.03M | 71.57M |
EPS (Basic) | -0.06 | -0.04 | -0.06 | -0.09 | -0.06 | -0.03 |
EPS (Diluted) | -0.06 | -0.04 | -0.06 | -0.09 | -0.06 | -0.03 |
EBITDA | -2.51M | -1.86M | -3.52M | -5.74M | -3.24M | -2.34M |
EBIT | -2.61M | -1.98M | -3.64M | -5.87M | -3.36M | -2.45M |
Depreciation & Amortization | 100K | 120K | 127K | 123K | 122K | 110K |
Add to Watchlist
Select watchlists to add or remove MENS